Topic: Focused ultrasound

Develop non-invasive neurotechnology based on focused ultrasound and targeted drug delivery. Projects may combine hardware and software, MRI-guided targeting, electrophysiology, closed-loop neuromodulation and preclinical experiments, with collaboration on clinical translation.

Lead research linking focused ultrasound, synthetic biology and cancer immunotherapy in Nate Yoon’s RPBS Lab. Projects include ultrasound-responsive gene circuits, immune-cell mechanotransduction and acoustic tools for imaging and therapy. Mentor students and develop an independent research trajectory in an interdisciplinary engineering environment. The expected start is 15 January 2027. Applications received by 1 October 2026 receive full consideration; the employer explicitly continues accepting applications until the position is filled.

WEBINAR 1 Breaking the barrier: Using focused ultrasound for the development of targeted therapies for brain tumours presented by Dr Ekaterina (Caty) Salimova, Monash Biomedical Imaging Glioblastoma multiforme (GBM) - brain cancer - is aggressive and difficult to treat as systemic therapies are hindered by the blood-brain barrier (BBB). Focused ultrasound (FUS) - a non-invasive technique that can induce targeted temporary disruption of the BBB – is a promising tool to improve GBM treatments. In this webinar, Dr Ekaterina Salimova will discuss the MRI-guided FUS modality at MBI and her research